Boothbay Fund Management’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-458,519
Closed -$4.79M 2389
2023
Q1
$4.79M Hold
458,519
0.1% 267
2022
Q4
$4.68M Hold
458,519
0.11% 252
2022
Q3
$4.59M Buy
+458,519
New +$4.59M 0.11% 212

Other funds holding SBC

Boothbay Fund Management's SBC Position: Q2 2023 in Review

Boothbay Fund Management sold out of SBC Medical Group (SBC) in Q2 2023, closing a stake of 458,519 shares — an estimated $4.79M sold.

Boothbay Fund Management first reported a position in SBC in Q3 2022 and held it in 3 quarters. The position peaked at $4.79M in Q1 2023. 13 funds tracked by Wall St. Rank hold SBC as of Q2 2023.

  • Boothbay Fund Management reported no remaining SBC Medical Group position as of Q2 2023 after selling out during the quarter.
  • Boothbay Fund Management sold 458,519 SBC Medical Group shares in Q2 2023, an estimated $4.79M.
  • Boothbay Fund Management first reported a position in SBC Medical Group in Q3 2022 and held it in 3 quarters.
  • Boothbay Fund Management's SBC Medical Group position peaked at $4.79M in Q1 2023.
  • 13 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2023.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.